Posted by Andrea Sparr-Jaswa.From Posted by Andrea Sparr-JaswaInternationalCBG and CBC Kill Gastrointestinal Cancer Cells in Preliminary StudyFunded by U.S. company Cannabics Pharmaceuticals, a firm focused on the development of cannabinoid therapies for cancer treatment, Israeli researchers have demonstrated the anti-tumor efficacy of CBG and CBC against human gastrointestinal cancer cell lines.January 27, 2020InternationalPre-Clinical Study Suggests CBG Is More Effective Than CBGA on Stomach and Bone CancersResearchers at Cannabics Pharmaceuticals in Israel have announced preliminary findings that show CBG may be more effective against human stomach and bone cancer cell lines than the acidic precursor, CBGA.January 10, 2020Legislation and RegulationAkers Bio Forms Advisory Board to Explore Involvement in the Hemp and Minor Cannabinoid MarketRecent FDA statements on the danger of CBD products in the open market and the need for DEA-regulated testing have given companies like Akers Bio an opportunity to explore a role in hemp and minor cannabinoid testing and processing.December 6, 2019Legislation and RegulationMinnesota Increases Medical Cannabis Program AccessThe Minnesota Department of Health announced the addition of chronic pain and age-related macular degeneration as qualifying conditions for the state's medical cannabis program on Monday. Two new delivery method options and the development of eight new patient center locations were also highlighted in the statement.December 4, 2019ComplianceHelix TCS Launches Nation's First Hemp Tracking System in Delaware to Ensure Consumer Transparency and SafetyAccess to hemp-sourced CBD is everywhere, but reliability in an unregulated market has proven problematic for consumer efficacy and safety. The new hemp tracking system released by Helix TCS for the state of Delaware seeks to improve trust and transparency within that supply chain.November 21, 2019Industry HeadlinesUCLA's Cannabis Research Initiative Awarded First Grant for Clinical Study from NIHThe National Institutes of Health has awarded a $3.5 million grant to UCLA's Cannabis Research Initiative to examine the pain-relieving effects of cannabis and its constituents in a clinical study. The study will also look at experiential differences associated with biological sex.November 21, 2019KentuckyNew Study Suggests Full-Spectrum Hemp CBD May Reduce or Eliminate Opioid Usage and Improve Quality of Life MeasuresEcofibre's Ananda Health Division reports promising results in largest-of-its-kind single-arm cohort study on opioid reduction and pain improvement using Kentucky-sourced hemp CBD.November 14, 2019Cannabis Branding Different StrainsLeafly Announces Certified Lab Program to Increase Access to Good Data and Validated ProductsCherry-picked potencies and inconsistent lab results have long drawn attention to the need for reliable standards in third-party testing. Leafly's new Certified Lab Program hopes to be a platform for consistent data and better consumer outcomes.November 12, 2019Page 1 of 1
